Inscription Capital, LLC Astrazeneca PLC Transaction History
Inscription Capital, LLC
- $620 Million
- Q1 2025
A detailed history of Inscription Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Inscription Capital, LLC holds 13,284 shares of AZN stock, worth $927,887. This represents 0.16% of its overall portfolio holdings.
Number of Shares
13,284
Previous 12,015
10.56%
Holding current value
$927,887
Previous $936,000
4.27%
% of portfolio
0.16%
Previous 0.14%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.99 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.84 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.49 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.19 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...